Abdelsalam, M.E.; Awad, A.; Bassett, R.L.; Lu, T.; Irwin, D.; Shah, K.Y.; Odisio, B.C.; Habibollahi, P.; Karam, J.A.; Matin, S.F.;
et al. Technique and Outcomes of Radiofrequency Ablation of Biopsy-Proven 3–4 cm T1a Renal Cell Carcinoma. Biomedicines 2025, 13, 1296.
https://doi.org/10.3390/biomedicines13061296
AMA Style
Abdelsalam ME, Awad A, Bassett RL, Lu T, Irwin D, Shah KY, Odisio BC, Habibollahi P, Karam JA, Matin SF,
et al. Technique and Outcomes of Radiofrequency Ablation of Biopsy-Proven 3–4 cm T1a Renal Cell Carcinoma. Biomedicines. 2025; 13(6):1296.
https://doi.org/10.3390/biomedicines13061296
Chicago/Turabian Style
Abdelsalam, Mohamed E., Ahmed Awad, Roland L. Bassett, Thomas Lu, David Irwin, Ketan Y. Shah, Bruno C. Odisio, Peiman Habibollahi, Jose A. Karam, Surena F. Matin,
and et al. 2025. "Technique and Outcomes of Radiofrequency Ablation of Biopsy-Proven 3–4 cm T1a Renal Cell Carcinoma" Biomedicines 13, no. 6: 1296.
https://doi.org/10.3390/biomedicines13061296
APA Style
Abdelsalam, M. E., Awad, A., Bassett, R. L., Lu, T., Irwin, D., Shah, K. Y., Odisio, B. C., Habibollahi, P., Karam, J. A., Matin, S. F., & Ahrar, K.
(2025). Technique and Outcomes of Radiofrequency Ablation of Biopsy-Proven 3–4 cm T1a Renal Cell Carcinoma. Biomedicines, 13(6), 1296.
https://doi.org/10.3390/biomedicines13061296